Publication | Open Access
Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141<sup>+</sup> dendritic cells to activate naïve and memory NY-ESO-1-specific CD8<sup>+</sup> T cells
37
Citations
41
References
2020
Year
These data advocate human CLEC9A-NY-ESO-1 Ab as an attractive strategy for specific targeting of CD141<sup>+</sup> DCs to enhance tumor immunogenicity in NY-ESO-1-expressing malignancies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1